staff reporter

News items for the in vitro diagnostics industry for the week of Oct. 11, 2021.

The companies will jointly develop an embedded image analysis workflow for pathologists that integrates PathAI algorithms into Roche's Navify software.

An estimated 43,000 people may have been given incorrect negative PCR test results between Sept. 8 and Oct. 12, mostly in the Southwest of England.

Earlier this year, Xtrava Health won funding from the National Institutes of Health to develop a SARS-CoV-2 antigen test that can be used at the point of care.

Last month, the agency alerted users to the potential of false positives due to overflow of the PCR reaction mixture into neighboring wells of the assay reagent tray.

The awards support the development, validation, scale-up, and manufacturing of the tests with the goal of bringing them to market as early as this year.

Imec said the agreement enables the commercialization of a device that enables aerosols and droplets from exhaled breath to be captured for screening.

Loop Medical said it is developing a minimally invasive blood collection device to collect sample volumes large enough that they are compatible with high-throughput blood analyzers.

The agreement with a single investor is for an aggregate 150,000 shares of convertible preferred stock and warrants to purchase up to 7.5 million shares of common stock.

The new test adds a third target for SARS-CoV-2 to enable better detection of the virus should it mutate further in the future.